CompletedNot Applicable

Response of Clostridium Difficile Infection to Metronidazole Therapy

United States290 participantsStarted 2005-06

Plain-language summary

In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * records of patients who have a fecal sample positive for C. difficile toxin and who are then treated for C. difficile colitis with oral metronidazole will be included in this study. Exclusion Criteria: * Patients who did not receive at least 7 days of metronidazole

Trial details

NCT IDNCT00304369

SponsorMichael E. DeBakey VA Medical Center

Sponsor typeFED

Study typeOBSERVATIONAL

Primary completion2007-06

View on ClinicalTrials.gov More Clostridium Enterocolitis trials